Literature DB >> 10669537

Mast-cell responses in the development of asthma.

C O Bingham1, K F Austen.   

Abstract

Many cells participate in the pathogenesis of asthmatic inflammation. The mast cell is localized at the interface of the internal and external environment within the lung where it may respond to allergens and other exogenous stimuli. The activation of mast cells leads to the release of mediators that contribute to the early phase of asthmatic inflammation. Mast-cell-derived products may also contribute to the late-phase asthmatic response. This review summarizes the developmental biologic features of the mast cell, its receptor-mediated activation, and its range of preformed, newly synthesized, and induced mediators that contribute to asthmatic inflammation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10669537     DOI: 10.1016/s0091-6749(00)90056-3

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  14 in total

1.  Increased expression of leukotriene C4 synthase and predominant formation of cysteinyl-leukotrienes in human abdominal aortic aneurysm.

Authors:  Antonio Di Gennaro; Dick Wågsäter; Mikko I Mäyränpää; Anders Gabrielsen; Jesper Swedenborg; Anders Hamsten; Bengt Samuelsson; Per Eriksson; Jesper Z Haeggström
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-15       Impact factor: 11.205

Review 2.  Regulation of mast cells by beta-agonists.

Authors:  Peter Peachell
Journal:  Clin Rev Allergy Immunol       Date:  2006 Oct-Dec       Impact factor: 8.667

3.  Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation.

Authors:  Linda J Kay; Wilfred W Yeo; Peter T Peachell
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

Review 4.  Mast Cell Activation Syndrome.

Authors:  Marianne Frieri
Journal:  Clin Rev Allergy Immunol       Date:  2018-06       Impact factor: 8.667

Review 5.  Mast cell activation syndrome: a review.

Authors:  Marianne Frieri; Reenal Patel; Jocelyn Celestin
Journal:  Curr Allergy Asthma Rep       Date:  2013-02       Impact factor: 4.806

6.  Human airway epithelial cell determinants of survival and functional phenotype for primary human mast cells.

Authors:  F H Hsieh; P Sharma; A Gibbons; T Goggans; S C Erzurum; S J Haque
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-26       Impact factor: 11.205

7.  Ablation of type I hypersensitivity in experimental allergic conjunctivitis by eotaxin-1/CCR3 blockade.

Authors:  Dai Miyazaki; Takao Nakamura; Masaharu Ohbayashi; Chuan Hui Kuo; Naoki Komatsu; Keiko Yakura; Takeshi Tominaga; Yoshitsugu Inoue; Hidemitsu Higashi; Meguru Murata; Shuzo Takeda; Atsuki Fukushima; Fu-Tong Liu; Marc E Rothenberg; Santa Jeremy Ono
Journal:  Int Immunol       Date:  2009-01-15       Impact factor: 4.823

Review 8.  Do mast cells link obesity and asthma?

Authors:  N Sismanopoulos; D-A Delivanis; D Mavrommati; E Hatziagelaki; P Conti; T C Theoharides
Journal:  Allergy       Date:  2012-10-16       Impact factor: 13.146

9.  The long-acting beta-adrenoceptor agonist, indacaterol, inhibits IgE-dependent responses of human lung mast cells.

Authors:  Anne-Marie Scola; Matthew Loxham; Steven J Charlton; Peter T Peachell
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

10.  Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice.

Authors:  Jian Liu; Adeline Divoux; Jiusong Sun; Jie Zhang; Karine Clément; Jonathan N Glickman; Galina K Sukhova; Paul J Wolters; Juan Du; Cem Z Gorgun; Alessandro Doria; Peter Libby; Richard S Blumberg; Barbara B Kahn; Gökhan S Hotamisligil; Guo-Ping Shi
Journal:  Nat Med       Date:  2009-07-26       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.